Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) suspends Phase II of SMA Drug Over Safety Concerns

Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) has suspended dosing in Phase II trial of PTC Therapeutics, Inc. (NASDAQ:PTCT) . The trial was for the development of spinal muscular atrophy (SMA) therapy. The suspension is due to safety problems stemming from the preclinical study. The drug, named RG7800 is currently in a 64 patient Phase II trial […]

Celgene Corporation (NASDAQ:CELG) to buy Cancer research Company Quanticel Pharmaceuticals

Celgene Corporation (NASDAQ:CELG) is buying up Quanticel Pharmaceuticals for a deal worth $485 million. The deal comes after Clegene teamed up with Versant Ventures to help Quanticel get off the ground Quanticel is a cancer focused biotech and has a drug recover engine that uses single cell genomic analysis to decode cancer cells and highlight […]

Stock Update: Alpha Natural Resources (NYSE:ANR); Johnson & Johnson (NYSE:JNJ) And Suncor Energy Inc. (USA) (NYSE:SU)

Boston, MA 02/05/2014 (wallstreetpr) – Alpha Natural Resources (NYSE:ANR), declared in a press release that four of its associateoperations have been admiredfor protecting the environment. Alpha has received the honors from two departments namely, West Virginia Department of Environmental Protection and the other being West Virginia Coal Association for its exceptional contribution towards reclamation, reforestation […]